21940565
2011 Oct
Objective:This report reviews the current clinical status of percutaneous ablation of hepatocellular carcinoma (HCC).Conclusion:HCC is increasing in incidence. Multiple percutaneous ablation methods are now available for primary treatment or for bridging to transplantation. Percutaneous ethanol instillation and radiofrequency ablation are the most extensively evaluated percutaneous treatments for HCC. Newer technologies are being evaluated and may change future practice patterns.

